SEC filing record
Primary Source · SEC.gov

Heritage Healthcare Innovation Fund IV, LP

Fund Vehicle2023 vintageRule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalSold increasedForm D/A · 2025-04-077 events: 2 sold increased, 2 investors increased, 2 large raiseLast filing 2025-04-07

Raised

$344M

Investors

51

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Heritage Healthcare Innovation Fund IV, LP is a Delaware limited partnership that first filed a Form D on April 10, 2023 and most recently amended it on April 7, 2025, describing itself as a private equity fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7) and covers pooled investment fund interests. Heritage Healthcare Innovation Fund IV, LP reported $344,475,246 sold from 51 investors of a $400,000,000 total offering as of the Form D filed April 7, 2025. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing checks both Section 3(c)(1), which caps the fund at 100 beneficial owners, and Section 3(c)(7), which requires every investor to be a qualified purchaser, generally an individual with at least $5 million in investments. A fund normally relies on one or the other. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names Houlihan Lokey Capital, Inc. (CRD 17708), associated with None as the recipient of sales compensation soliciting in all states. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 10 Burton Hills Boulevard, Suite 250, Nashville, TN 37215.

Critical Disclosures

What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.

Reporting lapsed · Form D · last filing April 7, 2025

Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.

Timeline
Each line is a fact as filed. The history behind it, the same event across other issuers, and an alert on the next one:Open in the terminal Watch this issuer

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001961281
Entity NameHeritage Healthcare Innovation Fund IV, LP
ExemptionRule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(1) of the Investment Company Act: the fund is excluded from investment-company registration because it has no more than 100 beneficial owners. Section 3(c)(7) of the Investment Company Act: the fund is excluded from investment-company registration because every investor is a qualified purchaser, generally an individual with at least $5 million in investments or an institution with at least $25 million.
Entity TypeLimited Partnership
Jurisdiction of OrganizationDelaware
Issuer Address10 Burton Hills Boulevard, Suite 250, Nashville, TN 37215
Phone(615) 665-8220
Industry / Fund TypePooled Investment Fund · Private Equity Fund
Investment Company ActExcluded under Section 3(c)(1) (100 beneficial owners or fewer) and Section 3(c)(7) (qualified purchasers only) (both boxes checked on the filing)
Securities TypePooled investment fund interests
First Sale DateApril 11, 2023
Filing DateApril 7, 2025
Accession Number0001961281-25-000001
Total Offering Amount$400,000,000
Total Amount Sold$344,475,246
Amount Remaining$55,524,754
Amount Sold NoteCombined figure across related vehicles: The total amount sold includes capital committed by the General Partner.
Total Investors51
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationIntended to last more than one year
Sales Commissions$0 (to Houlihan Lokey Capital, Inc.)
Finders' Fees$0
Revenue RangeNot Applicable
State (Issuer Address)TN
Amendment Count3 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

7

latest Apr 7, 2025

Critical / warning

0 / 0

6 watch · 1 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

dark

Latest event Sold increase · Apr 7, 2025

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Fund family Part of the Heritage Healthcare Innovation Fund family: 2 vehicles across 2 generations · adviser of record Hg Capital Management, LLC · full family and the filing behind each link in the terminal

Investor

  • The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
  • 7 filing events with values and deltas, latest 2025-04-07, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

HHIF IV GP, LLC

Executive Officer · Nashville, TN

"The general partner of the Issuer (the ""General Partner"")."

Jesse Bland

Executive Officer · Nashville, TN

Managing Director of the General Partner.

Lauren Brueggen

Executive Officer · Nashville, TN

Managing Director of the General Partner.

Bryan Bui

Executive Officer · Nashville, TN

Managing Director of the General Partner.

Graham Hunter

Executive Officer · Nashville, TN

Managing Director of the General Partner.

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

Houlihan Lokey Capital, Inc.CRD 17708 on BrokerCheck

Associated broker-dealer: None · Los Angeles, CA · Soliciting in all states

Questions About Heritage Healthcare Innovation Fund IV, LP

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Heritage Healthcare Innovation Fund IV, LP?

Heritage Healthcare Innovation Fund IV, LP is a Delaware limited partnership that filed a Form D with the SEC on April 7, 2025 as a private equity fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7) for an offering of pooled investment fund interests.

Is Heritage Healthcare Innovation Fund IV, LP legit?

AltStreet does not rate legitimacy; it reports the public record. Heritage Healthcare Innovation Fund IV, LP filed a Form D with the SEC on April 7, 2025 claiming Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $344,475,246 sold to 51 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Heritage Healthcare Innovation Fund IV, LP registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Heritage Healthcare Innovation Fund IV, LP claimed Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Heritage Healthcare Innovation Fund IV, LP raised?

Heritage Healthcare Innovation Fund IV, LP reported $344,475,246 sold from 51 investors of a $400,000,000 total offering as of the Form D filed April 7, 2025. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone.

Who can invest in Heritage Healthcare Innovation Fund IV, LP?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing checks both Section 3(c)(1), which caps the fund at 100 beneficial owners, and Section 3(c)(7), which requires every investor to be a qualified purchaser, generally an individual with at least $5 million in investments. A fund normally relies on one or the other. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in Heritage Healthcare Innovation Fund IV, LP?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling Heritage Healthcare Innovation Fund IV, LP and how are they paid?

The Form D names Houlihan Lokey Capital, Inc. (CRD 17708), associated with None as the recipient of sales compensation soliciting in all states. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Heritage Healthcare Innovation Fund IV, LP?

The Form D lists 5 related persons: HHIF IV GP, LLC, executive officer ("The general partner of the Issuer (the ""General Partner"")."); Jesse Bland, executive officer (Managing Director of the General Partner); Lauren Brueggen, executive officer (Managing Director of the General Partner); Bryan Bui, executive officer (Managing Director of the General Partner); Graham Hunter, executive officer (Managing Director of the General Partner). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Heritage Healthcare Innovation Fund IV, LP located?

The issuer's address on its SEC filings is 10 Burton Hills Boulevard, Suite 250, Nashville, TN 37215. Its phone number of record is 615-665-8220. It is organized under the laws of Delaware.

How long is the Heritage Healthcare Innovation Fund IV, LP offering open?

The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 2 amendments are on record for this CIK.

How large is Heritage Healthcare Innovation Fund IV, LP?

The Form D reports a revenue range of Not Applicable.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.